Human Subjects Protections in Biomedical Enhancement Research: Assessing Risk and Benefit and Obtaining Informed Consent

Journal of Law, Medicine and Ethics 36 (3):546-559 (2008)
  Copy   BIBTEX

Abstract

There are two critical steps in determining whether a medical experiment involving human subjects can be conducted in an ethical manner: assessing risks and potential benefits and obtaining potential subjects’ informed consent. Although an extensive literature on both of these aspects exists, virtually nothing has been written about human experimentation for which the objective is not to prevent, cure, or mitigate a disease or condition, but to enhance human capabilities. One exception is a 2004 article by Rebecca Dresser on preimplantation genetic modification — one of the most controversial enhancement technologies — in which she states, “Under existing research ethics principles, it would be unethical for investigators to perform modifications exposing embryos expected to develop into healthy children to significant risk in exchange for a possible physical or mental enhancement.” But Dresser does not explain why such an experiment would be unethical under existing principles, and her conclusion is not self-evident.

Other Versions

No versions found

Links

PhilArchive

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Vulnerable Subjects: Why Does Informed Consent Matter?Michele Goodwin - 2016 - Journal of Law, Medicine and Ethics 44 (3):371-380.
Making Risk-Benefit Assessments of Medical Research Protocols.Alex Rajczi - 2004 - Journal of Law, Medicine and Ethics 32 (2):338-348.
The Ethical Challenge of Human Research.Franklin G. Miller - 2012 - New York, US: Oxford University Press.

Analytics

Added to PP
2010-09-13

Downloads
107 (#462,635)

6 months
13 (#930,814)

Historical graph of downloads
How can I increase my downloads?